Introduction

Tukavo 50mg Tablet is a medicine used to treat a specific type of breast cancer called HER2-positive breast cancer, especially when it has spread to other parts of the body, including the brain. It is usually given along with two other medicines—trastuzumab and capecitabine.

The active ingredient, Tucatinib, works by blocking a protein (HER2) that helps cancer cells grow. By doing this, Tucatinib slows down or stops the cancer from spreading further. Tukavo 50mg Tablet is a targeted therapy, not traditional chemotherapy, which means it attacks cancer cells more specifically and causes less harm to healthy cells. Treatment should always be taken under a doctor’s supervision with regular checkups to ensure safety and effectiveness.

Uses

• HER2-positive advanced or metastatic breast cancer
• Brain metastases in HER2+ breast cancer patients
• Use in combination with trastuzumab and capecitabine after previous HER2-directed therapies

This therapy is typically considered when other standard HER2 treatments have become ineffective.

Side Effects

Common:

• Diarrhea (loose motion)
• Feeling very tired
• Nausea or vomiting
• Mouth sores
• Reduced appetite
• Red or sore hands and feet
• Liver test changes (seen in blood reports)

Serious (Call Your Doctor Right Away):

• Yellow skin or eyes (possible liver problem)
• Severe diarrhea with weakness
• Trouble breathing or swelling (possible allergic reaction)
• High fever or signs of infection

Frequently Asked Questions (FAQ)